Sernova Biotherapeutics Inc Share Price
Stocks
SVA
CA81752F1062
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
End-of-day quote
Toronto S.E.
14/08/2026
|
5-day change | 1st Jan Change | ||
| 0.1100 CAD | 0.00% |
|
-4.35% | -15.38% |
| Market Cap | 41.54M 29.93M 25.85M 24.3M 22.1M 2.86B 42.23M 285M 111M 1.43B 112M 110M 4.76B | P/E 2026 * |
-3.67x | P/E 2027 * | -2.75x |
|---|---|---|---|---|---|
| Enterprise Value | 41.54M 29.93M 25.85M 24.3M 22.1M 2.86B 42.23M 285M 111M 1.43B 112M 110M 4.76B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 8.31x |
| Free-Float |
86.84% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 week | -4.35% | ||
| 3 months | -29.03% | ||
| 6 months | -24.14% | ||
| Current year | -15.38% |
| 1 week | 0.1 | 0.12 | |
| 1 month | 0.1 | 0.12 | |
| Current year | 0.1 | 0.2 | |
| 1 year | 0.1 | 0.2 | |
| 3 years | 0.1 | 0.91 | |
| 5 years | 0.1 | 2.22 | |
| 10 years | 0.1 | 2.87 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jonathan Rigby
CEO | Chief Executive Officer | 58 | 11/08/2024 |
James Parsons
DFI | Director of Finance/CFO | 60 | 10/10/2024 |
David Burke
IRC | Investor Relations Contact | - | 10/10/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
James Parsons
BRD | Director/Board Member | 60 | 18/04/2012 |
Steven Sangha
BRD | Director/Board Member | - | 23/04/2023 |
David Paterson
BRD | Director/Board Member | - | 31/08/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 03/07/26 | Sell | Company | -115,000 | 0.0305% | ||
| 22/05/26 | Option | Director | 173,418 | 0.0499% | ||
| 27/02/26 | Option | Director | 377,970 | 0.1123% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | -4.35% | -45.00% | -86.59% | 29.93M | ||
| -0.55% | +0.05% | -11.18% | +20.45% | 130B | ||
| -0.86% | -1.53% | -18.54% | +2.14% | 12.49B | ||
| -2.60% | +2.51% | +105.35% | +148.76% | 10.88B | ||
| -2.43% | -4.22% | -44.57% | -67.28% | 4.51B | ||
| -0.88% | +0.67% | -24.25% | +42.34% | 2.72B | ||
| -1.32% | -1.42% | -21.31% | -13.79% | 1.66B | ||
| -0.17% | -0.04% | -33.47% | -35.74% | 1.66B | ||
| -1.89% | -5.09% | -34.94% | -75.32% | 1.65B | ||
| Average | -1.19% | -1.13% | -14.21% | -7.23% | 18.41B | |
| Weighted average by Cap. | -0.78% | -0.09% | -5.78% | +23.59% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 5M 3.6M 3.11M 2.92M 2.66M 345M 5.08M 34.26M 13.4M 173M 13.53M 13.23M 573M |
| Net income | -12.83M -9.24M -7.98M -7.5M -6.82M -884M -13.04M -87.9M -34.37M -443M -34.7M -33.95M -1.47B | -19.77M -14.25M -12.31M -11.56M -10.52M -1.36B -20.1M -135M -52.98M -682M -53.49M -52.33M -2.27B |
| Net Debt | - | - |
Employees
8
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/08/26 | CA$0.1100 | 0.00% | 5,147 |
| 13/08/26 | CA$0.1100 | -4.35% | 105,181 |
| 12/08/26 | CA$0.1150 | +4.55% | 134,600 |
| 11/08/26 | CA$0.1100 | 0.00% | 11,645 |
| 10/08/26 | CA$0.1100 | -4.35% | 106,500 |
Sell
Buy

Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.1100CAD
Average target price
0.4500CAD
Spread / Average Target
+309.09%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SVA Stock
Select your edition
All financial news and data tailored to specific country editions
















